Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment

• Ngā kaituhi matua: Dragan Primorac (Author), Martin Čemerin (Author), Vid Matišić (Author), Vilim Molnar (Author), Marko Strbad (Author), Lenart Girandon (Author), Lucija Zenić (Author), Miomir Knežević (Author), Stephen Minger (Author), Denis Polančec (Author)
• Hōputu: Pukapuka
• I whakaputaina: MDPI AG, 2021-09-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

The COVID-19 pandemic has significantly impacted the way of life worldwide and continues to bring high mortality rates to at-risk groups. Patients who develop severe COVID-19 pneumonia, often complicated with ARDS, are left with limited treatment options with no targeted therapy currently available....